amg-811
mAbexperimental
Clinical trial activity
4 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
4
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Dec 1, 2007 (NCT02291588)
Timeline
2000s
- Jan 1, 2007
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Interferon gammaINHIBITOR
IFNG inhibitor
- Interferon gammaImmunity, passive
IFNG immunity, passive
Chemistry & pharmacology
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL2109450 ↗
Also known as
- amg 811
- amg-811
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01510951 | Phase 1 | Aug 1, 2011 | Amgen |
| NCT01164917 | Phase 1 | Aug 1, 2010 | Amgen |
| NCT00818948 | Phase 1 | Mar 1, 2009 | Amgen |
| NCT02291588 | Phase 1 | Dec 1, 2007 | Amgen |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Amgen | For profit | 4 | 4 | 1 | 2007 |
1 organizations
Page 1 / 1